SCHEMBL8378583

SCHEMBL8378583

[CH2]CN(CCCCCCCCCCCC)CCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.50
TSHR P16473 2/20 0.44
THRB P10828 1/20 0.44
KCNH2 Q12809 3/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
GBA1 P04062 1/20 0.37
PLA2G1B P04054 1/20 0.37
PLA2G2A P14555 1/20 0.37
KDM5A P29375 2/20 0.36
PHF8 Q9UPP1 2/20 0.36
MCHR1 Q99705 1/20 0.36
KDM4C Q9H3R0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374808 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL8379915 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL292545 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL290988 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL3248572 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL8374761 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL8375294 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL8375333 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL8376140 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12
SCHEMBL8374768 1.00 DNM1 (0.50) DNM1TSHRTHRBKCNH2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4312951-A1 IMPLANTABLE MEDICAL DEVICE FOR THE DELIVERY OF NUCLEIC ACID-ENCAPSULATED PARTICLES Celanese EVA Performance Polymers LLC (US) 2024-02-07 EP disclosed
US-20240024422-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2024-01-25 US disclosed
EP-4186518-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ModernaTX, Inc. (US) 2023-05-31 EP disclosed
US-11571463-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2023-02-07 US disclosed
US-11311602-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2022-04-26 US disclosed
US-20210299221-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2021-09-30 US disclosed
US-11000573-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2021-05-11 US disclosed
US-20200376081-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF MODERNATX, INC. 2020-12-03 US disclosed
US-10646549-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2020-05-12 US disclosed
US-20190125839-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2019-05-02 US disclosed
EP-3458083-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF Modernatx, Inc. (US) 2019-03-27 EP disclosed
WO-2017201350-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF MODERNATX, INC. (US) 2017-11-23 WO disclosed
US-5986042-A Cross-linked polymer MITSUI CHEMICALS, INC. (JP) 1999-11-16 US disclosed
EP-0856539-A1 Cross-linked polymer Mitsui Chemicals, Inc. (JP) 1998-08-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11571463-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-11311602-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20210299221-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-10646549-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20200376081-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20240024422-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-11000573-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20190125839-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.